Factors Influencing Treatment Decision-Making In Patients With BRAF-Mutated Metastatic Melanoma

Source: OncLive, December 2023

Beyond symptoms, doctors consider the psychosocial factors impacting treatment access and adherence, like insurance coverage, cost, family support, and preexisting conditions, when deciding between immunotherapy and targeted therapy for patients with BRAF-mutated metastatic melanoma.
READ THE ORIGINAL FULL ARTICLE